Inhibition of human immunodeficiency virus type 1 activity in vitro by oligonucleotides composed entirely of guanosine and thymidine

Journal of Acquired Immune Deficiency Syndromes

Volumn 7, Issue 6, 1994, Pages 560-570

  Ojwang, Joshua ^a   Elbaggari, Ahmed ^b   Marshall, Helene B ^a   Jayaraman, Krishna ^a   McGrath, Michael S ^b   Rando, Robert F ^a  

^a Antigenics Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Deoxyguanosine; Deoxythymidine; Human immunodeficiency virus type; Oligonucleotide; Therapeutic

Indexed keywords

DEOXYGUANOSINE; GUANOSINE; OLIGONUCLEOTIDE; THYMIDINE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS INHIBITION;

ANIMAL; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; BASE SEQUENCE; BINDING, COMPETITIVE; CELL DIVISION; CELL LINE; GIANT CELLS; GUANOSINE; HIV CORE PROTEIN P24; HIV ENVELOPE PROTEIN GP120; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMAN; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES; PEPTIDE FRAGMENTS; REVERSE TRANSCRIPTASE INHIBITORS; THYMIDINE; VERO CELLS;

EID: 0028342861     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Milligan JF, Matteucci MD, Martin JC. Current concepts in antisense drug design. J Med Chem 1993;36:1923-37.
2. Zamecnik PC, Stephenson ML, Inhibition of rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci USA 1978;75:280-4.
3. Cohen JS. Antisense oligonucleotides as antiviral agents. Antivir Res 1991;16:121-33.
4. Marshall WS, Beaton G, Stein CY, Matsukura M, Caruthers MH. Inhibition of human immunodeficiency virus activity by phosphorothioate oligodeoxycytidine. Proc Natl Acad Sci USA 1992;89:6265-9.
5. Matsukura M, Shinozuka K, Zon G, Mitsuya FI, Reitz M, Cohen JS, Broder S. Phosphorothioate analogs of oligode- oxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc Natl Acad Sci USA 1987;84:7706-10.
6. Gao W, Stein CA, Cohen JS, Dutschman GE, Cheng YC. Effect of phosphorothioate homo-oligodeoxynucleotides on herpes simplex virus type 2-induced DNA polymerase. J Biol Chem 1989;264:11521-6.
7. Gao W, Flan FS, Storm C, Egan W, Cheng YC. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNAse H: implications for antisense technology. Molec Pharmacol 1992;41:223-9.
8. Marshall WS, Caruthers MH. Phosphorodithioate DNA as a potential therapeutic drug. Science 1993;259:1564-70.
9. Boiziau C, Thuong NT, Toulme JJ. Mechanisms of the inhibition of reverse transcription by antisense oligonucleotides. Proc Natl Acad Sci USA 1992;89:768-72.
10. Gao WY, Hanes RN, Vazquez-Padua MA, Stein CA, Cohen JS, Cheng YC. Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides. Antimicrob Agents Chemother 1990;34:808-12.
11. Gao WY, Jaroszewski JW, Cohen JS, Cheng YC. Mechanisms of inhibition of herpes simplex virus type 2 growth by 28-mer phosphorothioate oligodeoxycytidine. J Biol Chem 1990;265:20172-8.
12. Stein CA, Cleary AM, Yakubov L, Lederman S. Phosphorothioate oligodeoxynucleotides bind to the third variable loop domain (v3) of human immunodeficiency virus type 1 gp120. Antisense Res Develop 1993;3:19-31.
13. Durland RH, Kessler DJ, Gunnell S, Duvic M, Pettitt BM, Hogan ME. Binding of triple helix forming oligonucleotides to sites in gene promoters. Biochemistry 1991;30:9246-55.
14. Nelson PS, Frye RA, Liu E. Bifunctional oligonucleotide probes synthesized using a novel CPG support are able to detect single base pair mutations. Nucleic Acids Res 1989; 17:7187-91.
15. Vu H, Singh P, Joyce N, Hogan ME, Jayaraman K. Synthesis of cholesteryl supports and phosphoramidites containing a novel peptidyl linker for automated synthesis of triplehelix forming oligonucleotides and uses thereof. Second International (20th) Symposium on Nulceic Acids Chemistry. Sapporo, Japan, 1993.
16. Vu H, Hirschbein BL. Internucleotide phosphite sulfurization with tetraethylthiuram dissulfide: phosphorothioate oligonucleotide synthesis via phosphoramidite chemistry. Tetrahed Lett 1991;32:3005-8.
17. McGrath MS, Hwang KM, Caldwell S, et al. GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage. Proc Natl Acad Sci USA 1989;86:2844-8.
18. Parker WB, Bapat AR, Shen J-X, Townsend AJ, Cheng Y-C. Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primases, and ribonucleotide reductase. Molec Pharmacol 1988;34:485-491.
19. Cheung SC, Dietzschold B, Koprowski H, Notkins AL, Rando RF. A recombinant human Fab expressed in Escherichia coli neutralizes rabies virus. J Virol 1992;66:6714-20.
20. Orson FM, Thomas DW, McShan WM, Kessler DJ, Hogan ME. Oligonucleotide inhibition of IL2Ra mRNA transcription by promoter region collinear triplex formation in lymphocytes. Nucleic Acids Res 1991; 19:3435-41.
21. Stein C, Subasinghe C, Shinozuka K, Cohen J. Physiochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res 1988;16:3209-21.
22. Birg F, Praseuth D, Zerial A, Thuong NT, Asseline U, Le Doan T, Helene C. Inhibition of simian virus 40 DNA replication in CV-1 cells by an oligonucleotide covalently linked to an intercalating agent. Nucleic Acids Res 1990;18:2901-8.
23. Letsinger RL, Zhang G, Sun DK, Ikeuchi T, Sarin PS. Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture. Proc Natl Acad Sci USA 1989;86:6553-6.
24. Zendegui JG, Vasquez KM, Tinsley JH, Kessler DJ, Hogan ME. In vivo stability and kinetics of absorption and disposition of 3′ phosphopropyl amine oligonucleotides. Nucleic Acids Res 1991;20:307-14.
25. Ojwang J, Okleberry KM, Marshall HB, Huffman JH, Rando RF. Inhibition of friend murine leukemia virus activity by guanosine/thymidine oligonucleotides (submitted).
26. Fennewald S, Mustain S, Rando RF. Anti-herpes simplex virus activity of oligonucleotides composed entirely of guanine and thymine nucleosides, (submitted).
27. Segal IH. Enzyme kinetics, behavior and analysis of rapid equilibrium and steady state enzyme systems. New York: Wiley, 1975.
28. McDougal JS, Kennedy MS, Sligh JM, Cort SP, Mawle A, Nicholson JK. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science 1986;231:382-5.
29. Lisziewicz J, Sun D, Metelev V, Zamecnik P, Gallo RC, Agrawal S. Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates. Proc Natl Acad Sci USA 1993;90:3860-4.